You referenced a modified dose to conserve the medicine,
Do you have any insight on current and future availability ?
Do you have any insight on current and future availability ?
Marcus Aurelius said:
I find it kind of interesting the amount of fascination in the self-extubation part of the anecdote.
Marcus Aurelius said:
Yes - for the record - kudos to PatriotAg for hooking me up with the Genentech rep here to get the drug.
TexAgs: Knowing stuff when it really countsKeegan99 said:Marcus Aurelius said:
Yes - for the record - kudos to PatriotAg for hooking me up with the Genentech rep here to get the drug.
TexAgs out here saving lives on these Internet streets.
Marcus Aurelius said:
Yes - for the record - kudos to PatriotAg for hooking me up with the Genentech rep here to get the drug.
Marcus Aurelius said:
First experience with it. Patient with COVID-19 cytokine storm- typical ARDS high support vent. Fever, all typical inflammatory numbers climbing. Toci (IL-6 inhibitor) at 4mg/kg (to try to preserve drug - normal 8mg/kg dose) given. Next day. All inflammatory markers markedly lower. Patient self extubated and has remained off the vent with O2 support. Promising. Pure anecdote but thought I'd share.
Infection_Ag11 said:Marcus Aurelius said:
First experience with it. Patient with COVID-19 cytokine storm- typical ARDS high support vent. Fever, all typical inflammatory numbers climbing. Toci (IL-6 inhibitor) at 4mg/kg (to try to preserve drug - normal 8mg/kg dose) given. Next day. All inflammatory markers markedly lower. Patient self extubated and has remained off the vent with O2 support. Promising. Pure anecdote but thought I'd share.
This has been my experience. Only had one die who got an IL-6 inhibitor and they probably got it too late.
Everyone else has either gotten better or is getting better. The patient I spoke about over the weekend on the brink of death was extubated today after 7 days on the vent, 6 days after getting toci. One of the most surprising turnarounds in my time in medicine.
BusterAg said:
At least one other IL-6 inhibitor out there: siltuximab, (Sylvant by Jannsen).
Not sure if it would work as well as toxi, and inventories are likely lower since it only treats orphan diseases.
Others in trials.
DuncanAg said:oneeyedag said:
So did patient self extubate with the cuff inflated? If so impressive and dangerous.
Exactly what I was thinking...still inflated? I've obviously never seen that in an EMS setting.
How old is the patient?Marcus Aurelius said:
First experience with it. Patient with COVID-19 cytokine storm- typical ARDS high support vent. Fever, all typical inflammatory numbers climbing. Toci (IL-6 inhibitor) at 4mg/kg (to try to preserve drug - normal 8mg/kg dose) given. Next day. All inflammatory markers markedly lower. Patient self extubated and has remained off the vent with O2 support. Promising. Pure anecdote but thought I'd share.
Just wrapping up the webinar from Wuhan Central Hospital. It was difficult to follow at times, some of the Chinese MDs had limited English. My Mandarin is limited to a few words, none of which came up during the webinar.Marcus Aurelius said:
Gimme a rain check. I have patients tomorrow AM. Thanks for invite.
Any efficacy discussion? Especially for Chloroquine phosphate 500 mg BID?Kool said:Just wrapping up the webinar from Wuhan Central Hospital. It was difficult to follow at times, some of the Chinese MDs had limited English. My Mandarin is limited to a few words, none of which came up during the webinar.Marcus Aurelius said:
Gimme a rain check. I have patients tomorrow AM. Thanks for invite.
A few things I found interesting about their management:
They were doing 4 - 5 chest CT scans on their patients over the course of hospitalization. Seems like a lot of risk during transport, both in terms of virus spread to medical providers and risk for other "adverse events" during transfer.
They were doing a lot of bronchoscopies with lavage on their intubated patients, and they were also traching patients. Again, a lot of risk.
Mortality rate for intubated patients was/is 70%.
Strongest risk for needing intubation was RR greater than 30/min, others were 50% progression on serial chest radiology findings, 93% sat or less on RA, continuously decreasing lymphocyte count, marked increase in IL-6, CRP, D-dimer, LDH.
They gave steroids whenever SpO2 dropped below 93% at rest on RA, RR over 30, and PaO2/FiO2 less than 300 mm Hg.
Their antiviral drug regimen was Ribavirin 500 BID and Lopinavir/ritonavir 200/50 BID
Standard antiviral treatment (I assume for floor patients as well as in ICU) was
Alpha-interferon atomization 5 million U BID in sterile water
Lopinavir/ritonavir orally 2 capsules each BID
Ribavirin IV drip 500 mg BID - TID
Chloroquine phosphate 500 mg BID
Arbidol 200 mg TID
Further therapy was:
Methylprednisolone 40 mg IV BID, 20 mg "immunoglobulin" QD, and thymosin 1.6 mg Q 3 days, Moxifloxacin, Cefoperazone, and Linezolid, and LMWH 4,000 U daily.
At the end of this page was the bolded warning:
"Be cautious of side effects of these drugs, and combination of more than 3 kinds is NOT recommended".
They are seeing patients who have recovered who continue to test positive, stated about 15% will.
They have very limited experience with convalescent plasma.
They are doing trachs on patients ventilated over 7 - 10 days (again, seems really risky to everyone involved, but I suppose that is why they bronch so often).
D-dimer greater than 1 was and is a huge predictor of death. They anticoagulate all patients without contraindications.